NCT05126888 - SCI-110 in the Treatment of Tourette Syndrome | Biotech Hunter

Enrollment

164

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

February 28, 2026

Conditions

Tourette Syndrome

Interventions

DRUG

SCI-110

SCI-110 - a softgel capsule containing Dronabinol and Palmitoylethanolamide (PEA) in the following doses: 2.5mg Dronabinol+400mg PEA, 5mg Dronabinol+400mg PEA and 10mg Dronabinol+400mg. Maximum dose 20mg Dronabinol and 800mg PEA a day.

OTHER

Placebo

Pill that matches in taste, odour and appearance to SCI-110 active pills

Trial Locations (3)

30625

Medizinische Hochschule Hannover, Hanover

64239

Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv

06519

Yale Child Study Center - NIHB 205, New Haven